Keyword

oblimersen

Description: An antisense oligonucleotide drug designed to suppress BCL-2 expression and investigated as a cancer treatment.
Wikidata ID: wiki/Q7075165
OpenAlex ID: keywords/oblimersen
2002 · Richard J. Klasa, Amanda M. Gillum, et al. · Antisense and Nucleic Acid Drug Development · 299
2009 · Sanjiv S. Agarwala, Ulrich Keilholz, et al. · European Journal of Cancer · 152
2013 · Lydia Scarfò, Paolo Ghia · Immunology Letters · 126
2010 · Johannes Winkler, Martina Stessl, et al. · ChemMedChem · 104
2009 · P. Hersey, L. Bastholt, et al. · Annals of Oncology · 94
2009 · Michael Hallek · Hematology · 83
2010 · Michael Hallek, Natali Pflug · Annals of Oncology · 58
2008 · Catherine A. Tucker, Anita I. Kapanen, et al. · Molecular Cancer Therapeutics · 49
2005 · A CHANANKHAN · Blood Reviews · 49
2014 · Ahmed Kamal, Shaikh Faazil, et al. · Expert Opinion on Therapeutic Patents · 48
2012 · Patrick A. Ott, Jason Chang, et al. · Cancer Chemotherapy and Pharmacology · 48
2019 · Zeping Han, Jiening Liang, et al. · BioMed Research International · 46
2010 · Karim Abou-Nassar, Jennifer R Brown · PubMed · 43
Works count: 156
Citation count: 3,393
Year
Topic
Type